Access Official Technical PDF

Share Summary:LinkedInEmail

The Qualcomm antitrust ruling offers a useful case study in how courts assess competition in technology markets built around patents, industry standards and component supply chains. In 2020, the U.S. Court of Appeals for the Ninth Circuit reversed a district court judgment and vacated a worldwide injunction against Qualcomm. The court concluded that the Federal Trade Commission had not established that the challenged practices harmed competition in the cellular modem chip markets at issue.

Although the dispute concerned smartphone technology rather than industrial automation, its central questions are familiar across complex technology ecosystems: How should patent rights interact with shared technical standards? When does a supplier’s commercial strategy cross the line into unlawful exclusion? And what evidence is needed to show harm to competition rather than harm to individual rivals?

Why the Qualcomm antitrust ruling matters

Qualcomm develops cellular technologies, licenses patents and sells modem chips used in devices that connect to cellular networks. Its patent portfolio included standard-essential patents (SEPs)—patents covering technology required to implement a technical standard—as well as other patents. Because a SEP holder could otherwise block companies from implementing a standard, standards-setting organizations commonly require SEP holders to commit to licensing on fair, reasonable and nondiscriminatory (FRAND) terms.

The FTC alleged that Qualcomm’s practices unlawfully maintained monopoly power in CDMA and premium LTE modem chip markets. The district court agreed and ordered changes to several core business practices. On appeal, however, the Ninth Circuit focused on whether those practices had been shown to impair competition in the relevant chip markets.

OEM-level licensing and the duty to deal

Qualcomm generally licensed its patent portfolios to original equipment manufacturers (OEMs), such as cellphone makers, rather than licensing its SEPs directly to competing chip suppliers. It also offered rival chipmakers agreements under which Qualcomm would not assert its patents in exchange for commitments concerning sales to licensed OEMs.

The district court had found that Qualcomm was required by antitrust law to license its SEPs to rival chipmakers, relying on the narrow exception associated with Aspen Skiing. The Ninth Circuit rejected that conclusion, finding that the required elements for that exception were absent. In the court’s view, Qualcomm’s decision to license at the OEM level—even if unusual—did not by itself establish an antitrust violation.

The appellate court also separated the question of contractual FRAND obligations from antitrust liability. It said that if Qualcomm had breached a FRAND commitment, the appropriate remedy could lie in contract or tort law. The FTC, the court reasoned, had not adequately explained how an alleged breach of that commitment itself impaired rivals’ competitive opportunities. The court vacated the district court’s summary judgment ruling on the contractual issue as moot, without deciding its merits.

Assessing “no license, no chips”

Qualcomm’s “no license, no chips” policy meant it would not sell modem chips to an OEM that had not taken a license to Qualcomm’s patents. The FTC and the district court argued that this policy, alongside Qualcomm’s royalty structure, effectively placed an anticompetitive surcharge on rival chip suppliers: OEMs would owe royalties regardless of whose chips they purchased, potentially making rival chips more expensive in practice.

The Ninth Circuit did not accept that theory. It described the licensing and chip-sale practices as “chip-supplier neutral”: OEMs had to pay royalties for Qualcomm’s portfolio regardless of the chip supplier they selected. The court found that the FTC had not demonstrated that the policy imposed a surcharge on competing chip sales or undermined competition in the relevant markets.

This distinction is important in antitrust analysis. A business practice may affect individual competitors without necessarily harming the competitive process. The court emphasized that the relevant question was whether competition itself was harmed, not simply whether rivals faced difficult commercial conditions.

Evidence of competitive harm under the rule of reason

The court applied the rule of reason, which requires an assessment of a restraint’s actual effect on competition in a defined market. A plaintiff can seek to show harm directly, for example through evidence of reduced output, higher prices or lower quality. Alternatively, it can show market power together with evidence that the challenged conduct harms competition.

The Ninth Circuit concluded that the FTC had not met its initial burden under that framework. Because the case did not establish the necessary anticompetitive effect, the court was less critical of Qualcomm’s stated business justifications. It noted that OEM-level licensing appeared reasonable and consistent with current industry practice, while emphasizing that novelty alone does not make a business model unlawful.

The court also rejected the district court’s treatment of Qualcomm’s agreements with Apple. Those agreements included payments tied to Apple’s sourcing of modem chips from Qualcomm. The Ninth Circuit found that the agreements had not actually or practically foreclosed a substantial share of competition in the CDMA modem chip market. Apple had terminated them years earlier, so the court found nothing to enjoin on that basis.

Practical implications for technology and supply-chain leaders

For industrial automation companies that depend on standards-based technologies and multi-tier supplier relationships, the decision is a reminder to distinguish among three kinds of concerns:

  • Standards commitments: A FRAND commitment may create contractual obligations, but an alleged breach does not automatically prove an antitrust violation.
  • Competitive impact: Evidence should connect a challenged practice to effects in the specific market where competition is alleged to be restricted.
  • Rival disadvantage versus market harm: A supplier’s difficulty competing is not, by itself, proof that the competitive process has been harmed.

The ruling does not establish that every licensing strategy is lawful, nor does it settle the contractual meaning of Qualcomm’s FRAND commitments. Its narrower message is that antitrust claims require a demonstrated connection between the conduct and harm to competition in the relevant market.

Conclusion

The Ninth Circuit reversed the injunction because it found the FTC had not shown that Qualcomm’s OEM-level licensing, “no license, no chips” policy or Apple agreements unlawfully restrained competition in the modem chip markets. For technical decision-makers, the case underscores the importance of understanding how patent licensing, standards commitments and component sourcing interact—while keeping contractual disputes distinct from evidence-based claims of antitrust harm.

Access Official Technical PDF

About The Author